
USFDA APPLICATION NUMBER - 21356 / DOSAGE - TABLET;ORAL - 300MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| TENOFOVIR DISOPROXIL FUMARATE(UNII: OTT9J7900I) (TENOFOVIR ANHYDROUS - UNII:W4HFE001U5) | TENOFOVIR DISOPROXIL FUMARATE | 300mg |
Inactive Ingredients
| Ingredient Name | A-S Medication Solutions | REMEDYREPACK INC. | Apotex Corp. | Cipla USA Inc. | American Health Packaging | Teva Pharmaceuticals USA, Inc. |
|---|---|---|---|---|---|---|
| ALUMINUM OXIDE(LMI26O6933) | ||||||
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | ||||||
| CROSCARMELLOSE SODIUM(M28OL1HH48) | ||||||
| CROSPOVIDONE, UNSPECIFIED(2S7830E561) | ||||||
| FD&C BLUE NO. 2(L06K8R7DQK) | ||||||
| FD&C RED NO. 40(WZB9127XOA) | ||||||
| HYPROMELLOSE 2910 (15 MPA.S)(36SFW2JZ0W) | ||||||
| HYPROMELLOSE 2910 (15000 MPA.S)(288VBX44JC) | ||||||
| HYPROMELLOSE 2910 (5 MPA.S)(R75537T0T4) | ||||||
| HYPROMELLOSES(3NXW29V3WO) | ||||||
| INDIGOTINDISULFONATE SODIUM(D3741U8K7L) | ||||||
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | ||||||
| MAGNESIUM STEARATE(70097M6I30) | ||||||
| MANNITOL(3OWL53L36A) | ||||||
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | ||||||
| POLYETHYLENE GLYCOL 400(B697894SGQ) | ||||||
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | ||||||
| POLYSORBATE 80(6OZP39ZG8H) | ||||||
| POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990) | ||||||
| POVIDONE K30(U725QWY32X) | ||||||
| SILICON DIOXIDE(ETJ7Z6XBU4) | ||||||
| STARCH, CORN(O8232NY3SJ) | ||||||
| TALC(7SEV7J4R1U) | ||||||
| TITANIUM DIOXIDE(15FIX9V2JP) | ||||||
| TRIACETIN(XHX3C3X673) |